Preclinical studies demonstrate anti-tumor efficacy using sonodynamic therapy in glioblastoma, suggesting innovative delivery systems improve outcomes in patients.
Key Points
Sonodynamic therapy achieved significant anti-tumor efficacy in glioblastoma, with immune activation observed during treatment.
Reactive oxygen species generation was crucial to localized tumor cell killing via this innovative nanomedicine approach.
Clinical trials and preclinical studies support the potential of blood-brain barrier permeable delivery systems for effective treatments.
Advancements in delivery systems indicate that nanomedicine may enhance the safety and feasibility of sonodynamic therapy for brain tumors.